ScholarGate
Assistant

Comparer des méthodes

Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.

Pharmacovigilance PRR/ROR×Essai de perméabilité des cellules Caco-2×
DomainePharmacologiePharmacologie
FamilleProcess / pipelineProcess / pipeline
Année d'origine20021989
Auteur d'origineArne Melander and colleaguesIngrid Hidalgo
Typesafety signal detectionabsorption screening
Source fondatriceSzarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗
AliasPRR, ROR, signal detection, adverse event monitoringCaco-2 assay, intestinal permeability, ADME screening
Apparentées33
RésuméProportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.
ScholarGateJeu de données
  1. v1
  2. 2 Sources
  3. PUBLISHED
  1. v1
  2. 2 Sources
  3. PUBLISHED

Aller à la recherche Télécharger les diapositives

ScholarGateComparer des méthodes: Pharmacovigilance PRR/ROR · Caco-2 Permeability. Consulté le 2026-06-19 sur https://scholargate.app/fr/compare